1-5 of 5
Inhye E. Ahn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Consensus Recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment Selection and Sequencing in CLL or SLL

Jacob D Soumerai, Jacqueline Claudia Barrientos, Inhye E. Ahn, Catherine C. Coombs, Douglas E Gladstone, Marc S Hoffmann, Adam S Kittai, Ryan W Jacobs, Andrew Lipsky, Krish Patel, Joanna M Rhodes, Alan P Skarbnik, Meghan C. Thompson, Daniel A. Ermann, Patrick K Reville, Harsh R. Shah, Jennifer R Brown, Deborah M Stephens
Journal: Blood Advances
Blood Adv bloodadvances.2024014474.
https://doi.org/10.1182/bloodadvances.2024014474
Published: 2024
Includes: Supplemental data
Journal Articles

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Clinical Trials & Observations
Inhye E. Ahn, Danielle M. Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A. Walker, Robert Black, Josie Montegaard, Alvaro Alencar, Leyla Shune, Mohammad Omaira, Caron A. Jacobson, Philippe Armand, Samuel Y. Ng, Jennifer Crombie, David C. Fisher, Ann S. LaCasce, Jon Arnason, Ephraim P. Hochberg, Ronald W. Takvorian, Jeremy S. Abramson, Jennifer R. Brown, Matthew S. Davids
Journal: Blood Advances
Blood Adv (2024) 8 (4): 832–841.
https://doi.org/10.1182/bloodadvances.2023011574
Published: 2024
Includes: Supplemental data
Journal Articles

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting

Maissa Mhibik, Erika M. Gaglione, David Eik, John Herrick, Janet Le, Inhye E. Ahn, Christopher Chiu, Monica Wielgos-Bonvallet, Ida H. Hiemstra, Esther C. W. Breij, Jenny Chen, Edward B. Reilly, Pearlie K. Epling-Burnette, Edith Szafer-Glusman, Clare Sun, Adrian Wiestner
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4089–4101.
https://doi.org/10.1182/bloodadvances.2022009517
Published: 2023
Includes: Supplemental data
Journal Articles

BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL

Clinical Trials & Observations
Christopher Pleyer, Kerry J. Laing, Mir A. Ali, Christopher L. McClurkan, Susan Soto, Inhye E. Ahn, Pia Nierman, Emeline Maddux, Jennifer Lotter, Jeanine Superata, Xin Tian, Adrian Wiestner, Jeffrey I. Cohen, David M. Koelle, Clare Sun
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1732–1740.
https://doi.org/10.1182/bloodadvances.2021006574
Published: 2022
Includes: Supplemental data
Journal Articles

Early progression of disease as a predictor of survival in chronic lymphocytic leukemia

Clinical Trials & Observations
Inhye E. Ahn, Charles M. Farber, Matthew S. Davids, David L. Grinblatt, Neil E. Kay, Nicole Lamanna, Anthony Mato, Chadi Nabhan, Pavel Kiselev, Arlene S. Swern, E. Dawn Flick, Kristen Sullivan, Jeff P. Sharman, Christopher R. Flowers
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2433–2443.
https://doi.org/10.1182/bloodadvances.2017011262
Published: 2017
Includes: Supplemental data